Related Experiment Video

Updated: Jul 10, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Anoikis, initiated by Mcl-1 degradation and Bim induction, is deregulated during oncogenesis

Nicholas T Woods1, Hirohito Yamaguchi, Francis Y Lee

  • 1H. Lee Moffitt Cancer Center & Research Institute, University of South Florida, Tampa, Florida 33612, USA.

Cancer Research
|November 17, 2007
PubMed

Insights

Metastatic cancer cells evade anoikis, a cell death process, due to dysfunctional Mcl-1 degradation and Bim up-regulation. Restoring Mcl-1 degradation sensitizes these cells to anoikis, potentially preventing metastasis.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Molecular Oncology

Background:

  • Anoikis, a crucial form of apoptosis induced by cell detachment, is frequently impaired in metastatic cancers.
  • Dysfunctional anoikis contributes to cancer cell survival and metastasis.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying anoikis resistance in metastatic cancer cells.
  • To identify key regulators of anoikis initiation and explore therapeutic targets.

Main Methods:

  • Utilized NIH3T3 cells (wild-type and c-Src-transformed) and Saos-2/LM7 cell lines to model anoikis.
  • Investigated Mcl-1 degradation, Bim up-regulation, and their dependence on GSK-3beta, PI3K/Akt, and MAPK pathways.
  • Employed Mcl-1 knockdown and pharmacologic pathway inhibition in metastatic breast cancer cells.
  • Assessed anoikis sensitivity and in vivo metastasis prevention.

Main Results:

  • Detachment induced Mcl-1 degradation via a GSK-3beta-dependent proteasomal pathway and increased Bim expression.
  • Mcl-1 degradation coupled with Bim up-regulation initiated anoikis.
  • Metastatic cells exhibited dysregulated Mcl-1 degradation and Bim induction, leading to reduced anoikis sensitivity.
  • Inhibiting PI3K/Akt and MAPK pathways sensitized metastatic cells to anoikis and reduced metastasis in vivo.

Conclusions:

  • Mcl-1 degradation is a critical determinant for initiating anoikis by priming cells for Bax activation.
  • Oncogenic signaling pathways in metastatic cells block Mcl-1 degradation and Bim induction, conferring anoikis resistance.
  • Targeting Mcl-1 degradation and associated signaling pathways offers a potential therapeutic strategy to restore anoikis and inhibit metastasis.

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...